George D. Yancopoulos - 16 May 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**George D. Yancopoulos
Issuer symbol
REGN
Transactions as of
16 May 2024
Net transactions value
-$48,636,545
Form type
4
Filing time
17 May 2024, 16:06:52 UTC
Previous filing
17 May 2024
Next filing
12 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $877,432 -907 -0.11% $967.40 835,476 16 May 2024 Direct F1, F2
transaction REGN Common Stock Sale $3,111,598 -3,213 -0.38% $968.44 832,263 16 May 2024 Direct F1, F3
transaction REGN Common Stock Sale $9,210,174 -9,501 -1.1% $969.39 822,762 16 May 2024 Direct F1, F4
transaction REGN Common Stock Sale $4,530,144 -4,669 -0.57% $970.26 818,093 16 May 2024 Direct F1, F5
transaction REGN Common Stock Sale $4,782,018 -4,922 -0.6% $971.56 813,171 16 May 2024 Direct F1, F6
transaction REGN Common Stock Sale $768,054 -790 -0.1% $972.22 812,381 16 May 2024 Direct F1, F7
transaction REGN Common Stock Sale $2,583,491 -2,653 -0.33% $973.80 809,728 16 May 2024 Direct F1, F8
transaction REGN Common Stock Sale $7,416,996 -7,611 -0.94% $974.51 802,117 16 May 2024 Direct F1, F9
transaction REGN Common Stock Sale $9,015,386 -9,242 -1.2% $975.48 792,875 16 May 2024 Direct F1, F10
transaction REGN Common Stock Sale $4,771,277 -4,886 -0.62% $976.52 787,989 16 May 2024 Direct F1, F11
transaction REGN Common Stock Sale $1,199,245 -1,227 -0.16% $977.38 786,762 16 May 2024 Direct F1, F12
transaction REGN Common Stock Sale $370,730 -379 -0.05% $978.18 786,383 16 May 2024 Direct F1, F13
holding REGN Common Stock 5,903 16 May 2024 By 401(k) Plan
holding REGN Common Stock 180,000 16 May 2024 By Trust for Chldn. F14
holding REGN Common Stock 158,410 16 May 2024 by 2022 GRAT II
holding REGN Common Stock 18,148 16 May 2024 by Children
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.
F2 Represents volume-weighted average price of sales of 907 shares of Company stock on May 16, 2024 at prices ranging from $967.13 to $967.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 3,213 shares of Company stock on May 16, 2024 at prices ranging from $968.04 to $968.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 9,501 shares of Company stock on May 16, 2024 at prices ranging from $969.03 to $969.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 4,669 shares of Company stock on May 16, 2024 at prices ranging from $970.00 to $970.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 4,922 shares of Company stock on May 16, 2024 at prices ranging from $971.05 to $971.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 790 shares of Company stock on May 16, 2024 at prices ranging from $972.00 to $972.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 2,653 shares of Company stock on May 16, 2024 at prices ranging from $973.20 to $973.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 7,611 shares of Company stock on May 16, 2024 at prices ranging from $974.00 to $974.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 9,242 shares of Company stock on May 16, 2024 at prices ranging from $975.00 to $975.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F11 Represents volume-weighted average price of sales of 4,886 shares of Company stock on May 16, 2024 at prices ranging from $976.00 to $976.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F12 Represents volume-weighted average price of sales of 1,227 shares of Company stock on May 16, 2024 at prices ranging from $977.02 to $977.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F13 Represents volume-weighted average price of sales of 379 shares of Company stock on May 16, 2024 at prices ranging from $978.07 to $978.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 16, 2024 at each separate price.
F14 As investment trustee of trusts for the benefit of the reporting person's children.